JPMorgan Emerging Markets Growth and Income Plc (JMGI)

Biochemistry is a tough nut..so you must be a nerd 😂
It was one of the toughest courses I had to do during Pharmacy school..

v-WAVE 3.0*

Suggested Starting Cash Value For New AIM Accounts/Positions

Individual Stocks
High Risk: At or above 51%
Neutral: Between 37 and 50%
Low Risk: At or below 36%

Diversified Funds
High Risk: At or above 34%

Because EntangleX is built as a web-browser platform requiring no local installations, the cost to distribute it to new clients is practically zero. Once the software is coded, every new subscription or license sold represents almost pure profit, a stark contrast to their previous business costs.2.

Wade, the pick 4/10 contests are fun in many aspects, ex, when my pickers performed well, the board boss Sskillz1 would say "Congrats to our current leader VALUEMIND up 31.30% so far in the contest" and praised me, and when my pickers performed poorly, he never criticized me. I am very happy sharing

Yeah. They aren’t selling to people for individual consumption. You need regulatory approval as mentioned in PR
These are sales for research and investigational purposes.
Target market: Researchers.

BBAN,
All the 'Arguments' saying "75%/25%" is ONLY for "Retained Earnings" has ALREADY Been Proven Wrong!

When WMI-LT used the NOLs to create that a 'spin-off' shell company called "WMIH" and then gave '75%" of those Shares to the 'P' *& 'K' holders, then itself that Argument "

He has been sending out plenty of signals for those willing to listen.

He sure has. Plenty of signals that "I haven't sold a piece of silk, so here's a fluff piece to try to pump the declining stock price"

Thanks for the data. It appears that

we are on the verge of great things happening here.

i know, it needed a repost to keep people up to speed. i figured if i can listen to it again so can some one else, or better yet, some one new.......

Thank you for that reply.

When you don't have news worthy of reporting, do an interview with a magazine I've never heard of, then PR it.

Lower share structure here than Hawkins' other one that is price .0012

Easy .0025 here with this good share structure. Don't be fooled. Some people jealous of others' success.

This is a Hawkins ticker 🚀

From reading these posts it has become glaringly apparent poster is clearly out of ones arena . No facts are ever offered to substantiate claims of PPS increase. Nothing but mindless (FNMA) pumps from pink sheet trader . Probably best to pursue field more aligned with skill set like movie box office

late again I post that yestersday
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177779006

News this week imo. 

We're back to #1 on the Breakout board !!!

Genesis Holdings, Inc. (OTC: GNIS) reported approximately

1.86 million to 14.69 million common shares outstanding across recent financial overviews. Its authorized common shares are 2,000,000,000 as of the most recent annual filing period, though the company recently approved shareho

>>>It would be nice if information was provided before 2027. Annual reporting isn't often enough.

From the PR….Two Hands Corporation has submitted documentation to the State of Delaware in connection with a proposed corporate name change to "Quantum X Corporation." The Company has received verbal confirmation from the State of Delaware regarding the proposed name for Delaware corporate record pu

No I know. I majored in Biochem. Just saying. When you sell a product. You would want a physical bottle or something.

From this week's Barrons' - David Giroux:

You found great values in biotech and utilities in January. Where are you finding them now?

I will probably sound like a broken record for the next couple of years highlighting a unique opportunity in small- and mid-cap, or SMID

It is stated directly in the official press release issued by Two Hands Corporation on July 9, 2026.

Thanks boss! Expecting and hoping we start to move from Monday as more and more people detect the pieces of the puzzle 

GZ says he does not know anything about CHM review of the DCVax-L MAA or review by the OHEAG or CTBVEAG. He speaks solely as to MHRA review. I think his comments are useful to describe what is going on within NWBO regarding whether there is a lot of activity to respond to MHRA questions.

Link to verbal??